Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NEOPASALATE

AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID

Standard Dose
846MG;112MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEOPASALATE is listed in Drugs@FDA under application 080059 (ANDA).

Marketing status: Discontinued Active ingredient AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID Form and strength TABLET;ORAL - 846MG;112MG Sponsor MEDPOINTE PHARM HLC Submission history Latest submission status date: 1975-08-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEOPASALATE is listed in Drugs@FDA under application 080059 (ANDA). Marketing status: Discontinued Active ingredient AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID Form and strength TABLET;ORAL - 846MG;112MG Sponsor MEDPOINTE PHARM HLC Submission history Latest submission status date: 1975-08-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.